Folketrygdfondet’s Novo Nordisk NVO Stock Holding History

Folketrygdfondet’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$457M	Buy	9,522,383 +441,563	+5%	+$19M	9.85%	2
2026 Q1	$334M	Sell	9,080,820 -1,083,317	-11%	-$51.3M	5.92%	4
2025 Q4	$517M	Sell	10,164,137 -47,776	-0.5%	-$2.44M	12.04%	2
2025 Q3	$567M	Buy	10,211,913 +117,370	+1%	+$6.87M	13.25%	2
2025 Q2	$697M	Buy	10,094,543 +572,631	+6%	+$39M	15.53%	2
2025 Q1	$661M	Buy	9,521,912 +617,974	+7%	+$51M	14.73%	2
2024 Q4	$766M	Buy	8,903,938 +40,313	+0.5%	+$4.36M	17.2%	2
2024 Q3	$1.06B	Buy	8,863,625 +24,902	+0.3%	+$3.32M	20.72%	2
2024 Q2	$1.26B	Buy	8,838,723 +82,689	+0.9%	+$11M	22.27%	2
2024 Q1	$1.12B	Buy	8,756,034 +124,770	+1%	+$14.9M	24.39%	2
2023 Q4	$893M	Buy	8,631,264 +225,822	+3%	+$22.3M	18.17%	2
2023 Q3	$764M	Sell	8,405,442 -256,628	-3%	-$22.6M	15.83%	2
2023 Q2	$701M	Buy	8,662,070 +162,090	+2%	+$13.2M	16.05%	2
2023 Q1	$676M	Sell	8,499,980 -69,736	-0.8%	-$4.95M	16.05%	2
2022 Q4	$580M	Buy	8,569,716 +44,398	+0.5%	+$2.6M	12.3%	2
2022 Q3	$425M	Buy	8,525,318 +239,562	+3%	+$12.8M	9.52%	2
2022 Q2	$462M	Buy	8,285,756 +7,332,950	+770%	+$407M	9.69%	2
2022 Q1	$4.29M	Sell	952,806 -7,886,960	-89%	-$405M	2.52%	6
2021 Q4	$495M	Sell	8,839,766 -591,268	-6%	-$32M	11.95%	2
2021 Q3	$453M	Hold	9,431,034	–	–	11.36%	2
2021 Q2	$395M	Buy	9,431,034 +932,214	+11%	+$36.1M	11.69%	2
2021 Q1	$286M	Sell	8,498,820 -2,829,584	-25%	-$101M	9.78%	2
2020 Q4	$396M	Buy	11,328,404 +281,584	+3%	+$9.73M	14.59%	2
2020 Q3	$383M	Hold	11,046,820	–	–	16.09%	2
2020 Q2	$362M	Sell	11,046,820 -446,024	-4%	-$14.2M	14.62%	2
2020 Q1	$346M	Buy	11,492,844 +4,088	+0%	+$122K	16.71%	2
2019 Q4	$332M	Hold	11,488,756	–	–	10.85%	2
2019 Q3	$297M	Buy	11,488,756 +1,000,000	+10%	+$25.3M	10.32%	2
2019 Q2	$268M	Sell	10,488,756 -16,426	-0.2%	-$406K	9.26%	2
2019 Q1	$275M	Sell	10,505,182 -960,000	-8%	-$23.6M	8.8%	2
2018 Q4	$264M	Buy	11,465,182 +77,284	+0.7%	+$1.72M	8.8%	2
2018 Q3	$268M	Hold	11,387,898	–	–	6.87%	2
2018 Q2	$263M	Hold	11,387,898	–	–	7.2%	2
2018 Q1	$280M	Sell	11,387,898 -2,356,188	-17%	-$61.9M	8.44%	2
2017 Q4	$369M	Sell	13,744,086 -690,000	-5%	-$17.5M	11.09%	2
2017 Q3	$348M	Buy	14,434,086 +605,702	+4%	+$13.7M	11.45%	2
2017 Q2	$297M	Buy	13,828,384 +1,607,216	+13%	+$32.4M	11.64%	2
2017 Q1	$209M	Hold	12,221,168	–	–	8.24%	2
2016 Q4	$219M	Sell	12,221,168 -1,238,182	-9%	-$22.4M	6.29%	3
2016 Q3	$280M	Sell	13,459,350 -1,276,000	-9%	-$31.6M	8.25%	3
2016 Q2	$396M	Buy	14,735,350 +30,000	+0.2%	+$823K	11.12%	3
2016 Q1	$398M	Buy	14,705,350 +814,774	+6%	+$21.8M	12.65%	3
2015 Q4	$403M	Buy	13,890,576 +372,258	+3%	+$10.3M	12.25%	4
2015 Q3	$367M	Buy	13,518,318 +150,052	+1%	+$4.25M	11.05%	4
2015 Q2	$366M	Buy	13,368,266 +180,250	+1%	+$5.07M	9.82%	4
2015 Q1	$352M	Buy	13,188,016 +200,468	+2%	+$4.62M	9.72%	4
2014 Q4	$275M	Buy	+12,987,548	New	+$290M	7.52%	4

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Folketrygdfondet's NVO Position: Q2 2026 in Review

Folketrygdfondet increased its Novo Nordisk (NVO) stake by 4.9% in Q2 2026, buying an estimated $19M and bringing the position to 9,522,383 shares worth $457M. The position accounts for 9.85% of the portfolio, ranked #2.

Folketrygdfondet first reported a position in NVO in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.26B in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Folketrygdfondet held 9,522,383 shares of Novo Nordisk worth $457M as of Q2 2026.
Folketrygdfondet bought 441,563 Novo Nordisk shares in Q2 2026, an estimated $19M.
Novo Nordisk made up 9.85% of Folketrygdfondet's portfolio in Q2 2026, its #2 holding.
Folketrygdfondet first reported a position in Novo Nordisk in Q4 2014 and has held it in 47 quarters since.
Folketrygdfondet's Novo Nordisk position peaked at $1.26B in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Folketrygdfondet's 13F filing for Q2 2026, filed 13 Aug 2026.